# BCE Inc: financial statements, quarterly

BCE · NYSE · CIK 718940 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bce.md) · [Financials](/companies/bce/financials.md) · [Filings](/companies/bce/filings.md) · [Insiders](/companies/bce/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bce/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Current assets | $bn | not reported | [4.9](/filings/0000718940-18-000012.md) | [5.7](/filings/0000718940-19-000015.md) | [5.8](/filings/0001193125-20-069763.md) | [5.5](/filings/0001193125-21-077183.md) | [5.7](/filings/0001193125-22-065246.md) | [6.2](/filings/0001193125-23-059140.md) | [6.5](/filings/0001193125-24-063019.md) | [7.9](/filings/0001193125-25-049950.md) | [8.9](/filings/0001193125-26-095004.md) | [7.4](/filings/0001193125-26-095004.md) |
| Total assets | $bn | not reported | [50.1](/filings/0000718940-18-000012.md) | [55.8](/filings/0000718940-19-000015.md) | [57.1](/filings/0001193125-20-069763.md) | [60.1](/filings/0001193125-21-077183.md) | [60.7](/filings/0001193125-22-065246.md) | [66.8](/filings/0001193125-23-059140.md) | [69.3](/filings/0001193125-24-063019.md) | [71.9](/filings/0001193125-25-049950.md) | [73.5](/filings/0001193125-26-095004.md) | [80.2](/filings/0001193125-26-095004.md) |
| Current liabilities | $bn | not reported | [10.1](/filings/0000718940-18-000012.md) | [10.7](/filings/0000718940-19-000015.md) | [10.4](/filings/0001193125-20-069763.md) | [9.8](/filings/0001193125-21-077183.md) | [8.3](/filings/0001193125-22-065246.md) | [9.1](/filings/0001193125-23-059140.md) | [11.5](/filings/0001193125-24-063019.md) | [12.1](/filings/0001193125-25-049950.md) | [14.8](/filings/0001193125-26-095004.md) | [12.9](/filings/0001193125-26-095004.md) |
| Total liabilities | $bn | not reported | [32.3](/filings/0000718940-18-000012.md) | [35.2](/filings/0000718940-19-000015.md) | [36.4](/filings/0001193125-20-069763.md) | [38.7](/filings/0001193125-21-077183.md) | [39.3](/filings/0001193125-22-065246.md) | [43.8](/filings/0001193125-23-059140.md) | [46.8](/filings/0001193125-24-063019.md) | [51.4](/filings/0001193125-25-049950.md) | [56.1](/filings/0001193125-26-095004.md) | [56.9](/filings/0001193125-26-095004.md) |
| Shareholders' equity | $bn | [17.3](/filings/0000718940-18-000012.md) | [17.5](/filings/0000718940-18-000012.md) | [20.3](/filings/0000718940-19-000015.md) | [20.4](/filings/0001193125-20-069763.md) | [21.1](/filings/0001193125-21-077183.md) | [21.0](/filings/0001193125-22-065246.md) | [22.6](/filings/0001193125-23-059140.md) | [22.2](/filings/0001193125-24-063019.md) | [20.2](/filings/0001193125-25-049950.md) | [17.1](/filings/0001193125-26-095004.md) | [23.0](/filings/0001193125-26-095004.md) |

- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 912,274,545 at 2023-12-31, from the cover of the [40-F filed 2024-03-08](/filings/0001193125-24-063019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.